GR3029392T3 - Transdermal therapeutic system containing octyl dodecanol as crystallization inhibitor - Google Patents

Transdermal therapeutic system containing octyl dodecanol as crystallization inhibitor

Info

Publication number
GR3029392T3
GR3029392T3 GR990400476T GR990400476T GR3029392T3 GR 3029392 T3 GR3029392 T3 GR 3029392T3 GR 990400476 T GR990400476 T GR 990400476T GR 990400476 T GR990400476 T GR 990400476T GR 3029392 T3 GR3029392 T3 GR 3029392T3
Authority
GR
Greece
Prior art keywords
pct
system containing
therapeutic system
transdermal therapeutic
crystallization inhibitor
Prior art date
Application number
GR990400476T
Other languages
English (en)
Inventor
Guenter Cordes
Lucio C Rovati
Original Assignee
Rotta Research Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotta Research Lab filed Critical Rotta Research Lab
Publication of GR3029392T3 publication Critical patent/GR3029392T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR990400476T 1993-10-01 1999-02-12 Transdermal therapeutic system containing octyl dodecanol as crystallization inhibitor GR3029392T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4333595A DE4333595A1 (de) 1993-10-01 1993-10-01 Transdermales therapeutisches System zur Applikation von Arzneimitteln auf die Haut
PCT/EP1994/003269 WO1995009618A1 (de) 1993-10-01 1994-09-30 Transdermales therapeutisches system enthaltend octyldodecanol als kristallisationsinhibitor

Publications (1)

Publication Number Publication Date
GR3029392T3 true GR3029392T3 (en) 1999-05-28

Family

ID=6499233

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990400476T GR3029392T3 (en) 1993-10-01 1999-02-12 Transdermal therapeutic system containing octyl dodecanol as crystallization inhibitor

Country Status (12)

Country Link
US (1) US5711962A (el)
EP (1) EP0721334B1 (el)
JP (1) JPH09503217A (el)
AT (1) ATE175346T1 (el)
AU (1) AU680050B2 (el)
CA (1) CA2172738A1 (el)
DE (2) DE4333595A1 (el)
DK (1) DK0721334T3 (el)
ES (1) ES2130446T3 (el)
FI (1) FI961435A (el)
GR (1) GR3029392T3 (el)
WO (1) WO1995009618A1 (el)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU559553B2 (en) * 1981-09-11 1987-03-12 Dayco Products, Inc. Belt tensioner, part therefor, and methods of making the same
US5252334A (en) * 1989-09-08 1993-10-12 Cygnus Therapeutic Systems Solid matrix system for transdermal drug delivery
HU228434B1 (en) * 1995-06-07 2013-03-28 Ortho Mcneil Pharm Inc Transdermal medicament for administering 17-deacetyl norgestimate alone or in combination with an estrogen
DE19526864A1 (de) * 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster
DE19548332A1 (de) * 1995-12-22 1997-07-10 Rotta Res Bv Hormonpflaster
DE19700913C2 (de) * 1997-01-14 2001-01-04 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Hormonen
DE19738855C2 (de) * 1997-09-05 2001-01-04 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit haftklebender Reservoirschicht und unidirektional elastischer Rückschicht
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
DE19828273B4 (de) * 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
DE19828274C2 (de) * 1998-06-25 2002-11-28 Rottapharm Bv Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
US7025979B2 (en) 2000-02-15 2006-04-11 Schering Ag Male contraceptive formulation comprising norethisterone
US20060142257A1 (en) * 2001-01-19 2006-06-29 Eberhard Nieschlag Male contraceptive formulation comprising norethisterone
GB2373421B (en) * 2001-03-16 2004-04-14 Cambridge Broadband Ltd Wireless communication system
WO2002102390A1 (en) * 2001-06-18 2002-12-27 Noven Pharmaceuticals, Inc. Enhanced drug delivery in transdermal systems
WO2004014395A1 (ja) 2002-08-09 2004-02-19 Teikoku Seiyaku Co.,Ltd. 女性ホルモン含有貼付剤
JP4824963B2 (ja) 2004-08-12 2011-11-30 日東電工株式会社 貼付材及び貼付製剤
JP4745747B2 (ja) 2004-08-12 2011-08-10 日東電工株式会社 フェンタニル含有貼付製剤
WO2009139411A1 (ja) 2008-05-15 2009-11-19 久光製薬株式会社 パロノセトロンを含有する経皮吸収製剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2902414A1 (de) * 1979-01-23 1980-08-07 Hoechst Ag Depotkoerper auf basis silicon- kautschuk sowie verfahren zu seiner herstellung
ATE23356T1 (de) * 1980-06-05 1986-11-15 Smith & Mclaurin Verfahren zur herstellung eines wasseraktivierbaren, klebenden beschichtungsmaterials auf der basis von staerke.
DE3634016A1 (de) * 1986-04-17 1987-10-29 Lohmann Gmbh & Co Kg Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung
FR2612785A1 (fr) * 1987-03-25 1988-09-30 Lhd Lab Hygiene Dietetique Dispositif auto-adhesif d'administration d'un principe actif par voie percutanee
CH674618A5 (el) * 1987-04-02 1990-06-29 Ciba Geigy Ag
JPH0745062B2 (ja) * 1987-10-30 1995-05-17 川崎重工業株式会社 二重管製造方法
WO1991003219A1 (en) * 1989-09-08 1991-03-21 Cygnus Research Corporation Solid matrix system for transdermal drug delivery
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
DE3942232A1 (de) * 1989-12-21 1991-06-27 Beiersdorf Ag Schmelzhaftkleber auf acrylatbasis
DE4020144A1 (de) * 1990-06-25 1992-01-09 Lohmann Therapie Syst Lts Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen
US5198223A (en) * 1990-10-29 1993-03-30 Alza Corporation Transdermal formulations, methods and devices
DE4210711A1 (de) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren
IT1253265B (it) * 1991-11-25 1995-07-14 Rotta Research Lab Preparato a matrice copolimerica adesiva a base acrilica per il rilascio transdermico dell'estradiolo.

Also Published As

Publication number Publication date
AU680050B2 (en) 1997-07-17
FI961435A0 (fi) 1996-03-29
DK0721334T3 (da) 1999-08-30
FI961435A (fi) 1996-03-29
DE59407605D1 (de) 1999-02-18
AU7784494A (en) 1995-05-01
ES2130446T3 (es) 1999-07-01
WO1995009618A1 (de) 1995-04-13
DE4333595A1 (de) 1995-04-06
CA2172738A1 (en) 1995-04-13
JPH09503217A (ja) 1997-03-31
US5711962A (en) 1998-01-27
EP0721334B1 (de) 1999-01-07
ATE175346T1 (de) 1999-01-15
EP0721334A1 (de) 1996-07-17

Similar Documents

Publication Publication Date Title
GR3029392T3 (en) Transdermal therapeutic system containing octyl dodecanol as crystallization inhibitor
DE59507188D1 (de) Transdermale therapeutische systeme enthaltend sexualsteroide
IL109448A0 (en) Risperidone pamoate, its preparation and pharmaceutical compositions containing it
CA2034934A1 (en) Transdermal Therapeutic System Comprising Tulobuterol as Active Substance
FR05C0045I2 (el)
IL111077A0 (en) Pharmacologically active pyridine derivatives and processes for the preparation thereof
CA2119745A1 (en) Nonpeptidyl integrin inhibitors having specificity for gpiibiiia receptor
AU7994594A (en) Plaster for the treatment of nail mycoses
HU9501719D0 (en) Polypeptide and anti-hiv agent prepared therefrom
HU9600592D0 (en) Preparation for substitution therapy, containing at least one progestogen and at least one extrogen
HK1002017A1 (en) Lyospheres comprising gonadotropin
AU685075B2 (en) Pharmaceutical composition for treating nicotine dependence
EP0537165A4 (en) POLYMER DRUG DISPENSING SYSTEM.
PL313327A1 (en) Percutaneous therapeutic system
IL111942A0 (en) A transdermal therapeutic system containing a parasympathomimetic compound and a parasympatholytic compound
GR3024157T3 (en) Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy.
AU6190098A (en) Composition suitable for inhibiting potato sprouting and/or fungoid growth
IL111917A0 (en) A pharmaceutical composition containing a parasympathomimetic compound and a parasympatholytic compound
AU7460894A (en) Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis
TW261516B (el)
CA2251353A1 (en) Transdermal delivery device for azapirone compounds
GR3035785T3 (en) Transdermal presentation of nitroglycerin for preventing undesired labour
CA2152280A1 (fr) Utilisation du riluzole comme radiorestaurateur